chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle aches all over; His hands aches; Joint pain, aches in joints; He just feels out of energy, he just feels down; He just feeling terrible; He felt lot worse and was not feeling great at all; Little ache in his arm where they gave him a shot; Little bit of worst feeling kind of achy here and there; Little off balance in walking; This is a spontaneous case from a contactable consumer or other non-health care professional reported for himself. A 79-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EL9266 and expiry date: do not know it has an expiration date and he did not see an expiration date), via an unspecified route of administration on 19Feb2021 (at the age of 79-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history was not provided. Concomitant medications included Amlodipine 25mg (dose was not clarified) with unknown start date and unknown if ongoing, once in night, he thinks it lowers blood pressure. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 29Jan2021 (at the age of 79-year-old) as dose 1, single for COVID-19 immunization. The patient went for his second shot, when he got call from hospital and said that he should went up there earlier in a day, but he was last person up there for the shot. It was on late afternoon on Friday about 5:00. However, he got the shot and returned home. On 20Feb2021 (next day, on Saturday), he has little ache in his arm where they gave him a shot, little bit of worst feeling kind of achy here and there and little off balance in walking. On Saturday, when he received, the date he went there. He does not know what date Saturday was. On 21Feb2021 (on Sunday), he felt lot worse and was not feeling great at all and just stayed in bed lying down all day. On 22Feb2021 (on Monday), the late day he just feeling terrible, he can hardly do anything much and went to work in yard today, but he feels out of energy and muscle aches all over and joint pain, aches in joints and even his hands aches, no headache. His sense of taste was fine, he just feels down. Patient asked that if this was just common to have the aches and pains after the injection and how long will it last. Therapeutic measures were reported as no, stated that he has not done anything, just stayed in bed, and tried to eat little soup as he does not know what to do. The outcome of the events was reported as unknown.  Follow-up attempts completed. No further information expected.
From initial information received on 24OCT2003 from a physician regarding an adverse event occurring in the USA it was reported that a 57 year old female received a dose of FLUZONE, administered IM in the right deltoid on 21OCT2003. The following day, the patient developed a local reddened area at the injection site. She was seen by a physician the next day. At that time, the patient had a 15cm x 15cm indurated area at the site and a red macular rash on her upper extremities and torso. She also reported slight pruritus. The patient had not recovered from these events at the time of this report.
swelling at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 4X733, expiry date 8th March 2021) for prophylaxis.   On 28th July 2020, the patient received the 1st dose of Shingrix. On 28th July 2020, less than a day after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb was recovered/resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient after the dose of Shingrix in the right arm experienced swelling at the injection site on the right arm that lasted 2 to 3 days, mentioned the size was about 100mm. The reporter consent to follow up.
Patient had onset of symptoms, fever, chills, cough, SOB on 12/27/21; was tested positive for Covid -19 on 1/9/22 and admitted to hospital on 1/9/22. Patient developed pneumonia and remained hospitalized for 5 days.
nausea, fever, chills, tiredness for 48 hours.  Stayed home from work until better
High fever (103.5) approximately 8 hours after shot, persisting for 3 days at over 101 with Tylenol every 4-6 hours Body aches and chills lasting for 24 hours Nausea and vomiting for 72 hours after injection Diarrhea for 72 hours after injection  Bitter taste in mouth and all food tastes bitter ? still persisting as of 4/10/21 Patches of dry skin on left side of face that burn and itch and are flaky. Areas are swollen and hot to the touch? appeared on 4/7/21 and as of 4/10/21 still there.
Information has been received from a nurse practitioner referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On approximately 30-JUN-2015 (reported as either 30-JUN-2015 or 01-JUL-2015), the patient was vaccinated with one dose of VARIVAX (Merck) (lot# L002214, expiration date 21-JAN-2017; route unknown) after it had a temperature excursion (incorrect product storage). Information regarding the concomitant medication was unknown. It was unknown if there was any relevant laboratory data. At the time of this report, it was unknown if the patient would ever get the VARIVAX (Merck) again and the outcome of the VARIVAX (Merck) being given after an excursion was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Urticaria pruritus and anxiety. Epinephrine 0.3 mg once.
Flu-like symptoms; Sore throat; Arm pain that lasted 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain that lasted 24 hours), INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A. Expiration date:) for COVID-19 vaccination.     Concurrent medical conditions included Chronic tonsillitis.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain that lasted 24 hours). On 03-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat). On 10-Apr-2021, PAIN IN EXTREMITY (Arm pain that lasted 24 hours) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was provided i.e.,   Vick Syrup Amoxicillin 500mg PO TID
Extreme swelling to left underarm(lymph node) hardness and swelling noted first evening of shot. Tenderness to left groin area Numbness and weakness to left hand and fingers especially fifth finger. Fever blister formed On bottom lip.  Underarm swollen and warm. No low grade temp notes but I do not experience elevated temps when sick as a general rule.
Expired vaccine used/take out one to two vials and place in fridge each day as needed; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/take out one to two vials and place in fridge each day as needed) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/take out one to two vials and place in fridge each day as needed). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/take out one to two vials and place in fridge each day as needed) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the Reporter  No Treatment Information were provided by the Reporter
Unable to keep liquids and food  down for over 11 days. Had to receive IV fluids and nutrients.
No Adverse event; received doses out of the wrong vial/get the bivalent vaccine, but they got the original.; This spontaneous case was reported by a medical assistant and describes the occurrence of WRONG PRODUCT ADMINISTERED (received doses out of the wrong vial/get the bivalent vaccine, but they got the original.) and NO ADVERSE EVENT (No Adverse event) in a 71-year-old male patient who received mRNA-1273 (Spikevax) (batch no. AR5186C) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Oct-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (received doses out of the wrong vial/get the bivalent vaccine, but they got the original.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received doses out of the wrong vial/get the bivalent vaccine, but they got the original.) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received doses out of the wrong vial/get the bivalent vaccine, but they got the original.).    No concomitant information was reported. It was reported that there were no temperature excursions involved, and the vaccine was not expired. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-666042 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-666042:
Acute thyroiditis; unknown cause; low TSH in January 2023 and high TSH in February 2023; prescribed levothyroxine; follow-up scheduled for June 2023
11cm area of erythema and slight induration on left upper lateral thigh. Treatment with Benadryl PO qb PRN and ice to site PRN.
Went over what vaccines were needed including if they wanted the covid vaccine. At first parent wanted it but was unable to produce the vaccine card. Asked if they were able to get and parent was unsure. Explained if they were unable to produce proof of the covid vaccine and they still wanted it they could get it but it will be restarting the series over. The first covid vaccine that was being given that day would be the first one of the series. Parent did voice that it was understood that the child would be starting the series over beginning with today as the first dose. The parent decided to restart the series. The first Pfizer monovalent was given.
Rash/Hive on upper chest-used Cortisone cream and Claritin allergy pill Arm soreness & fluctuating low grade fever used Tylenol and Advil topical muscle rub on arm
This spontaneous report as received from a nurse practitioner via company representative refers to an 18 year old female patient. Patient's concurrent condition, concomitant medications and medical history was not provided. On an unknown date, the patient was vaccinated with first dose of GARDASIL 9. On 08-DEC-2015, the patient was vaccinated with second dose of GARDASIL instead of GARDASIL 9. There was no product quality complaint reported. Additional information has been requested.
Fever up to 105.2 - had seizure. Measle like rash all over body. Post seizure child stopped breathing and ambulance called.
Transient small bowel - small bowel intussusception with reduction during ultrasound. Screaming episodes x12 hours with diarrhea x3 days prior with blood in stool day of presentation. No fever.
pain at the site; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 19Feb2021 (Lot number: EN5318) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "psoriasis" (unspecified if ongoing), notes: Verbatim: Psoriasis. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose: EL9262), administration date: 29Jan2021, when the patient was 46 years old, for COVID-19 immunisation, reaction(s): "pain". The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "pain at the site".  Additional information: After my second injection on 19Feb2021, I had pain at the site, but my range of motion was not impacted. (same arm).  No follow-up attempts are possible. No further information is expected.
Woke up 04/22/04 with high fever (102.2).  After Tylenol, slept most of the day.  Woke up that evening, took a shower, complained if sore left arm.  Left arm swollen, sore and red from shoulder to elbow.  Continued to run fever, given Benadryl for 2 days.  Slowly swelling went down.  Saw physician at this time.  Swelling only around injection site on Sunday. 04/25/04
Dizziness followed by heavy feeling in legs  followed by loss of balance and extreme difficulty in walking
t105 for 1 1/2 days p/vax APAP would not bring fever down;
I had a quick onset of being sensitive to cold; I started having chills, and I had a fever about a half hour later. I felt some weakness. The fever lasted all night. I tried to break it with Tylenol - 102. 3; Tylenol didn't break it - around 11:30 or 12 that night. I waited throughout the night. I would improve and then the fever would come down to 99 and then it would come back up and then after that it stayed high. I took temperature that night about 10:30 and by morning,  (1/28/2021)I checked into the Medical Center Dr. to get checked. They gave me an IV and they did some labs and were checking for COVID. Tylenol was through IV.  They had to check my scrotum - they said that I had fluid or excess fluid in my scrotum.  I was better by the time I left ER. I felt fine after one o'clock.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 9:49 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 9:49 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 67.79 for dose administered on 27-Oct-2021. No concomitant medications were reported. Batch number 035C21A underwent temperature excursion on 27-Oct-2021 with temperature 29 to 32 degrees Fahrenheit from 09:00 am to 10:00 AM. These vials were moved to fridge on 29-Sep-2021 and 5-Oct-2021 and beyond use date for the vials was reported as 29-Oct-221 and 04-Nov-2021 respectively. Product moved to clinic on 27-Oct-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported
Site: Pain at Injection Site-Mild, Systemic: mentrual changes-Mild, Additional Details: headaches, no appetite, stomach ache, light sensitivity, fatigue, mentrual cycle distrupted. Patient states she got her period 2 weeks early. She takes an oral contraceptive pill, she did not miss any
Received a MMR Vaccination around 11:30 AM on Monday 2/3/03. Broke out with hives on her body around 10:00PM Tuesday 2/4/03.
Vaccination exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy) in a 31-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 042L20A) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 22-Jun-2020 and the estimated date of delivery was 29-Mar-2021. On 26-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy.  On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy) had resolved.            Concomitant and treatment medications were not reported. Patient delivered 3 live, full-term birth babies. Lab data includes ultrasound 2020 normal, blood screen 2020 normal and glucose tolerance nove 2020 normal. 20 Jul 2020, the pregnancy test was positive.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Appx 10-12 hours after vaccine, developed redness, warmth, and swelling in the left thigh around site of injection. Fever the next day 101F.  Redness spread the following day to about 7 cm x 5 cm and persisted to today.
Pt. received a Sequirus Fluad quadrivalent for 65 years and over on 10/4/22 during pharmacy clinic.  On 10/6/22 he was noted to have redness, swelling, peeling, and blisters around both lips that lasted almost a week.  Petroleum jelly was ordered with no effect.  Abreva was ordered TID x 5 days and Docosanol cream.   The swelling has resolved with a few small resolving sores.
first reaction about 4 1/2 hours after injection.. fine powdery itchy rash on breasts pectoral area and ribs.  approx 30 hours after injection sudden onset fatigue, extreme pain in injection arm, uncontrolable chills, low grade fever,headache. approx 44 hours later still headache, muscle pain subsided, powdery itchy rash returned.. over chest , pectoral area , and itchy eyes and head..
Headache, chills, sweating, fatigue, nausea, body aches Lasted 2 days.
High fever and related effects: prostration, shivering, fatigue. Fever started shortly after injection.  Left work at 3:30, went to bed. Fever broke next morning.
The patient was administered an expired vaccine in error. The patient had no adverse reaction or complications. The patient and primary care provider were notified of the error. Steps have been taken to assure this will not occur again.
pt  accidentally recv vax intradermally & devel an inj sit rxn, characterized by a hard, red, raised area;
FELT LIGHTHEADED AND C/O NAUSEA POST VACCINE. REPORTS FEAR/ANXIETY WITH NEEDLES. IMPROVED UPON ARRIVING TO OBS, AMBULATED WITHOUT DIFFICULTY. GIVEN WATER AND SNACK PRIOR TO ARRIVING TO OBS, FELT BETTER. ORTHOSTATIC VSS. FELT SIMILAR S/S ALONG WITH FEELING HOT AND "WORKED UP" PTA. ONCE S/S RESOLVED, ESCORTED TO EXIT WITH NO FURTHER ISSUES AT 1545. 1528 INITIAL/LYING BP 143/82 HR 88 RR 18 SATS 100% RA 1532 SITTING BP 97/79 HR 99 RR 20 SATS 100% 1535 REPEAT SITTING BP 137/70 HR 91 RR 20 SATS 98% RA 1537 STANDING BP 115/77 HR 88 RR 20 SATS 99% RA
A symptomatic papular rash at site of his injection approximately 1 wk later suggest topical cream
Information has been received from a physician for a case in litigation concerning a 7 year old male who in approximately 1998 was vaccinated with MMR II, also referred to as the "triple measles vaccine" by the physician. The pt presented with a history of recent psychomotor retardation without any associated history or signs of an infectious or neoplastic process. Investigation concluded that the etiology lay in a subacute sclerosing panencephalitic process attributable to the MMR II. The pt manifested no allergies to egg protein and his immediate post vaccination course had been uneventful. There had been no evidence of measles prior to the vaccination and his psychomotor development had been normal until the onset of symptoms. Subsequently, in approximately August 2001 the pt died.
On day 6 after I had trouble with my concentration my right arm started trembling with uncontrollable tremors and my speech started to slur and I couldn?t get my words out. My friend came over that?s a nurse and talked to me we didn?t think it was a stroke or if it was it was a mini one because I could start to tak and came back to normal with in a couple of hours. By wednesday the symptoms started again. I went to the Emergency Room. They determined that it has to be neurological and I am following up with my primary care. I have an MRI scheduled May 3rd
I experienced upper abdominal pain and it would not go away. I went to the urgent care and it turns out it was gall bladder stones.
One small red bump appeared two days post-vaccination in the center of patient's chest area. Over the course of 6 weeks, the bumps spread throughout their body until they were completely covered. Then the bumps would burst, causing the patient pain. Pt. was prescribed skin creams by former PCM (flight doctor) to help mitigate symptoms and was eventually seen out in town, where he was given Benadryl IM. When this failed, he was given more highly concentrated Benadryl IM doses and finally experienced some relief to his ongoing symptoms with the second shot.